​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast

Boston Scientific (BSX) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $120.83, with a high of $130.00 and a low of $115.00. This represents a 13.84% increase from the last price of $106.14.

$35 $54 $73 $92 $111 $130 High: $130 Avg: $120.83 Low: $115 Last Closed Price: $106.14

BSX Stock Rating

Boston Scientific stock's rating consensus is Buy, based on 42 Wall Street analysts. The breakdown includes 2 Strong Buy (4.76%), 37 Buy (88.10%), 3 Hold (7.14%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 42 0 3 37 2 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks

TypeNameUpside
StockBoston Scientific13.84%
SectorHealthcare Stocks 18.80%
IndustryMedical Device Stocks18.11%

Price Target Trends

1M3M12M
# Anlaysts1215
Avg Price Target$121.00$119.50$106.80
Last Closing Price$106.14$106.14$106.14
Upside/Downside14.00%12.59%0.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 258232-134
Jun, 258233--34
May, 257234--34
Apr, 256234-134
Mar, 256234-134
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 21, 2025Jayson BedfordRaymond James$121.00$103.8016.57%14.00%
Jun 16, 2025Mike KratkyLeerink Partners$118.00$101.4916.27%11.17%
Apr 24, 2025Richard NewitterTruist Financial$117.00$100.5516.36%10.23%
Feb 18, 2025Argus Research$130.00$105.3523.40%22.48%
Feb 03, 2025Matt O'BrienPiper Sandler$115.00$103.0711.57%8.35%
Jan 02, 2025Vijay KumarEvercore ISI$100.00$89.3811.88%-5.78%
Dec 30, 2024Marie ThibaultBTIG$101.00$89.6812.62%-4.84%
Oct 24, 2024Shagun SinghRBC Capital$98.00$87.4512.06%-7.67%
Oct 24, 2024Kristen StewartC.L. King$90.00$87.452.92%-15.21%
Oct 21, 2024William PlovanicCanaccord Genuity$98.00$88.0711.28%-7.67%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 24, 2025RBC CapitalOutperformOutperformhold
Jul 21, 2025Raymond JamesStrong BuyStrong Buyhold
May 22, 2025CitigroupBuyBuyhold
Apr 23, 2025BTIGBuyBuyhold
Apr 18, 2025CitigroupOutperformOutperformhold
Apr 16, 2025NeedhamHoldBuyupgrade
Feb 03, 2025Cowen & Co.BuyBuyhold
Feb 03, 2025Piper SandlerOverweightOverweighthold
Jan 10, 2025Deutsche BankHoldBuyupgrade
Jan 08, 2025BernsteinOutperformOutperformhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.10$0.69$0.45$1.08$1.26----
Avg Forecast$1.04$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.07$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.03$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-109.62%-57.14%-73.99%-46.27%-48.99%----

Revenue Forecast

$5B $10B $15B $20B $25B $30B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.91B$11.89B$12.68B$14.24B$16.75B----
Avg Forecast$10.03B$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$10.21B$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$9.91B$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %-1.15%0.12%-0.02%0.88%0.83%----

Net Income Forecast

$-500M $1B $3B $4B $6B $7B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-140.00M$1.04B$698.00M$1.59B$1.85B----
Avg Forecast$1.53B$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.56B$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$1.50B$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %-109.16%9.89%-23.22%1.46%-48.65%----

BSX Forecast FAQ

Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 42 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 37 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 42 Wall Street analysts, averages $120.83 over the next 12 months. The price target range spans from $115 at the low end to $130 at the high end, suggesting a potential 13.84% change from the previous closing price of $106.14.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 13.84% upside, underperforming the average forecast for the healthcare stocks sector (18.80%) and underperforming the medical device stocks industry (18.11%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • July 2025: 23.53% Strong Buy, 67.65% Buy, 5.88% Hold, 0% Sell, 2.94% Strong Sell.
  • June 2025: 23.53% Strong Buy, 67.65% Buy, 8.82% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 20.59% Strong Buy, 67.65% Buy, 11.76% Hold, 0% Sell, 0% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2025 is $2.81, marking a 123.02% increase from the reported $1.26 in 2024. Estimates for the following years are $3.2 in 2026, $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2025 is $18.79B, reflecting a 12.21% increase from the reported $16.75B in 2024. The forecast for 2026 is $20.7B, followed by $22.61B for 2027, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2025 stands at $4.11B, representing an 121.97% increase from the reported $1.85B in 2024. Projections indicate $4.68B in 2026, $3.93B in 2027, and $5.8B in 2028.